Compound Planning Inc. Has $1.51 Million Stock Position in CVS Health Corporation $CVS

Key Points

• Compound Planning Inc. increased its stake in CVS Health by 53%, now owning 22,223 shares valued at approximately $1.5 million as reported in SEC filings.
• Analyst ratings are largely positive, with several firms reissuing "buy" ratings and adjusting price targets, reflecting a consensus target price of $76.67 for CVS shares.
• CVS Health reported strong quarterly earnings of $1.81 per share, exceeding estimates, and generated revenue of $98.92 billion for the quarter, indicating an 8.4% year-over-year growth.

Compound Planning Inc. grew its position in CVS Health Corporation (NYSE:CVS - Free Report) by 53.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,223 shares of the pharmacy operator's stock after acquiring an additional 7,694 shares during the period. Compound Planning Inc.'s holdings in CVS Health were worth $1,506,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of CVS. Goldman Sachs Group Inc. increased its holdings in shares of CVS Health by 87.5% in the first quarter. Goldman Sachs Group Inc. now owns 9,927,650 shares of the pharmacy operator's stock valued at $672,598,000 after purchasing an additional 4,632,530 shares in the last quarter. Nuveen LLC bought a new stake in shares of CVS Health during the 1st quarter valued at $204,421,000. Fairfax Financial Holdings Ltd. Can bought a new stake in shares of CVS Health during the 4th quarter valued at $121,742,000. Assenagon Asset Management S.A. raised its position in shares of CVS Health by 310.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 3,523,824 shares of the pharmacy operator's stock valued at $238,739,000 after acquiring an additional 2,666,029 shares during the last quarter. Finally, Invesco Ltd. raised its position in shares of CVS Health by 13.2% during the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator's stock valued at $1,383,039,000 after acquiring an additional 2,375,764 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Stock Performance

Shares of NYSE:CVS traded up $0.39 on Wednesday, reaching $71.94. 3,445,374 shares of the company's stock were exchanged, compared to its average volume of 9,733,428. The company has a fifty day moving average of $65.66 and a 200-day moving average of $65.42. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The company has a market capitalization of $91.24 billion, a price-to-earnings ratio of 20.09, a PEG ratio of 0.79 and a beta of 0.58. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the business posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were given a dividend of $0.665 per share. The ex-dividend date was Tuesday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.7%. CVS Health's dividend payout ratio (DPR) is currently 74.30%.

Analysts Set New Price Targets

Several analysts have commented on CVS shares. Jefferies Financial Group upped their target price on shares of CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, June 30th. Wells Fargo & Company reissued an "overweight" rating and issued a $84.00 price target (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Royal Bank Of Canada boosted their price target on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. Robert W. Baird raised shares of CVS Health from a "neutral" rating to an "outperform" rating and boosted their price target for the company from $71.00 to $82.00 in a report on Thursday, August 14th. Finally, Barclays boosted their price target on shares of CVS Health from $79.00 to $80.00 and gave the company an "overweight" rating in a report on Friday, August 1st. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $77.56.

Insider Activity

In other news, Director Guy P. Sansone purchased 1,570 shares of CVS Health stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the transaction, the director owned 12,007 shares of the company's stock, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.